# Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center

> **NCT01465360** · — · COMPLETED · sponsor: **Exonhit** · enrollment: 160 (actual)

## Conditions studied

- Alzheimer's Disease
- Mild Cognitive Impairment
- Vascular Dementia
- Fronto-temporal Dementia
- Primary Progressive Aphasia
- Parkinson' Disease Dementia
- Mixed Dementia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01465360
- **Lead sponsor:** Exonhit
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2012-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01465360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01465360, "Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT01465360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*